HB 95 Delaware House · 151st General Assembly (2021-2022)

AN ACT TO AMEND TITLE 18, TITLE 29, AND TITLE 31 OF THE DELAWARE CODE RELATING TO INSURANCE COVERAGE OF EPINEPHRINE AUTOINJECTORS.

Summary

This Act requires that individual, group, State employee, and public assistance insurance plans provide coverage for epinephrine autoinjectors for individuals who are 18 years of age or under and must include at least 1 formulation of epinephrine autoinjectors on the lowest tier of the drug formulary developed and maintained by the carrier if the insurance plan has tiers.

Bill status signed all 5 stages cleared

Introduction

Jan 2021

Committee Review

Mar 2021

House Passage

Mar 2021

Senate Passage

Mar 2021

Signed into Law

Jun 2021

Introduced Jan 28, 2021 Signed Jun 15, 2021

Floor votes · Senate Mar 31, 2021 · House Mar 25, 2021

How they voted

20–0

Passed

Total votes 20

Mar 31, 2021

D Democratic13

13 Yea

100% Yea

R Republican7

7 Yea

100% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jun 15, 2021

Signed into law

Signed by Governor

executive

Mar 31, 2021

Upper · Passed

Passed By Senate. Votes: 21 YES

upper

Mar 30, 2021

Upper · Passed

Reported Out of Committee (Health & Social Services) in Senate with 5 Favorable

upper

Mar 25, 2021

Introduced

Assigned to Health & Social Services Committee in Senate

upper

Mar 25, 2021

Lower · Passed

Passed By House. Votes: 40 YES 1 ABSENT

lower

Mar 9, 2021

Lower · Passed

Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 5 Favorable, 6 On Its Merits

lower

Jan 28, 2021

Introduced

Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House

lower

3 primary · 26 co-sponsors